In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BostonGene Corp.

https://www.bostongene.com/

Latest From BostonGene Corp.

LegoChem Brings Late Christmas Cheer With $1.7bn ADC Deal

LegoChem Biosciences has sealed yet another sizable out-licensing agreement with a global big pharma firm, this time with Janssen, underlining the continued keen global interest in ADCs.

South Korea Deals

Financing Quarterly Statistics, Q2 2022

During Q2, biopharmas brought in an aggregate $12.5bn in financing and device company fundraising totaled $3.7bn; while in vitro diagnostic firms and research tools players raised $720m.

Deals Financing

Tech Transfer: BMS, Evotec Partner With Four UK Universities On Translational Research Efforts

The firms hope academic research can yield first-in-class therapies and spinout companies. Also, Yale unveils research alliances with three biotechs.

Tech Transfer Round-Up Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Digital Health
    • Artificial Intelligence
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
UsernamePublicRestriction

Register